Skip to content

Caprosyn CC-925Recalls & reported problems

Covidien LP · Monofilament Absorbable Suture · Class 2 · Implant

All models of Caprosyn (45)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10884521034358), received between Mar 11, 2020 and Nov 12, 2020 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Break1
  • Unraveled Material1

Patient problems

  • No Consequences Or Impact To Patient1
  • Wound Dehiscence1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 12, 2020Unraveled Material; Unraveled Material

    ACCORDING TO THE REPORTER, 6 DAYS FOLLOWING THE CLOSURE OF FASCIA AND UTERUS ON A CAESAREAN PROCEDURE, WOUND DEHISCENCE WAS OBSERVED. THE PATIENT WAS RE-ADMITTED TO CLOSE THE DEHISCENCE OF THE LAYERED WOUND.

    Patient problems: Wound Dehiscence

    MAUDE report 10833148 ↗
  • MalfunctionMar 11, 2020Break; Break

    ACCORDING TO THE REPORTER, DURING PROCEDURE, WHILE EMPLOYING THE CONTINUOUS SUTURING TECHNIQUE, THE THREADS OF TWO SUTURES BROKE.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 9821306 ↗

Other SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC ACID devices

All SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC ACID devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page